These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3007761)

  • 1. Geometrical correspondence between phenazocine and the enkephalins.
    Froimowitz M; Matthysse S
    J Med Chem; 1986 Apr; 29(4):573-8. PubMed ID: 3007761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
    Loew GH; Lawson JA; Uyeno ET; Toll L; Frenking G; Polgar W; Ma LY; Camerman N; Camerman A
    Mol Pharmacol; 1988 Sep; 34(3):363-76. PubMed ID: 2843751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation-activity study of 4-phenylpiperidine analgesics.
    Froimowitz M
    J Med Chem; 1982 Oct; 25(10):1127-33. PubMed ID: 7143349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
    Loew GH; Berkowitz DS; Burt SK
    NIDA Res Monogr; 1978; (22):278-316. PubMed ID: 213725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred conformers for the pharmacologically typical and atypical antipodes of phenylmorphan opiates.
    Froimowitz M
    J Med Chem; 1984 Sep; 27(9):1234-7. PubMed ID: 6471078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists.
    Feinberg AP; Creese I; Snyder SH
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4215-9. PubMed ID: 186791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy conformation study of Met-enkephalin and its D-Ala2 analogue and their resemblance to rigid opiates.
    Loew GH; Burt SK
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):7-11. PubMed ID: 272674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to mu and delta opiate receptors.
    Mihara H; Lee S; Shimohigashi Y; Aoyagi H; Kato T; Izumiya N; Costa T
    Biochem Biophys Res Commun; 1986 May; 136(3):1170-6. PubMed ID: 3013169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational search in enkephalin analogues containing a disulfide bond.
    Froimowitz M
    Biopolymers; 1990; 30(11-12):1011-25. PubMed ID: 2081263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.
    Heyman JS; Vaught JL; Mosberg HI; Haaseth RC; Porreca F
    Eur J Pharmacol; 1989 Jun; 165(1):1-10. PubMed ID: 2548877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposals for conformation of enkephalins related to opiate mu-pharmacophore.
    Maigret B; Premilat S; Fournie-Zaluski MC; Roques BP
    Biochem Biophys Res Commun; 1981 Mar; 99(1):267-74. PubMed ID: 6263272
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of the stereo-orientation of aromatic groups in enkephalins to opiate receptor recognition.
    Shimohigashi Y; Costa T; Nitz TJ; Chen HC; Stammer CH
    Biochem Biophys Res Commun; 1984 Jun; 121(3):966-72. PubMed ID: 6331436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational properties of butaclamol and isobutaclamol. Regularities in the structures of semirigid neuroleptics.
    Froimowitz M; Matthysse S
    Mol Pharmacol; 1983 Sep; 24(2):243-50. PubMed ID: 6193405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
    Froimowitz M; Pick CG; Pasternak GW
    J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational studies and receptor binding of delta selective opioid peptides.
    Keys C; Amsterdam P; Payne P; Toll L; Loew G
    NIDA Res Monogr; 1986; 75():57-60. PubMed ID: 2829004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
    J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enkephalins and opiates: structure-activity relations.
    Horn AS; Rodgers JR
    J Pharm Pharmacol; 1977 May; 29(5):257-65. PubMed ID: 17687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of p-nitrophenylalanine enkephalins with mu-, delta- and kappa-subtypes of the opiate receptor.
    Fauchère JL; Do KQ; Schwyzer R; Robson LE; Gillan MG; Paterson SJ; Kosterlitz HW
    Eur J Pharmacol; 1982 Feb; 77(4):339-42. PubMed ID: 6277677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for specific recognition of mu or delta opiate receptors.
    Fournie-Zaluski MC; Gacel G; Maigret B; Premilat S; Roques BP
    Mol Pharmacol; 1981 Nov; 20(3):484-91. PubMed ID: 6276710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.